Clinical
India’s Pharma Industry Expected To Reach US$55 Billion by 2020
A new study details how India’s exports of pharmaceuticals is predicted to rapidly expand in the coming decade, reaching US$25 billion by 2014 and US$55 billion by 2020.
More Clinical Articles
Clinical
Big Pharma Should Tackle Antibiotics Emergency Together, says Report Author
Comments from the UK chief medical officer this week reveal her fears for the future state of the global health system as diseases have become resistant to existing drugs. A co-author of the report calls on Big Pharma to provide a united front in the next war on bacteria.
Clinical
Pharma CEOs Call for Public-Private Alzheimer’s Partnership
Several major pharma companies have teamed up with multinational businesses from other sectors in calling for the development of a global action plan to prevent and treat Alzheimer’s disease by 2025.
Clinical
Real World Data: Medical Device and Diagnostics Perspectives
Jill E. Sackman examines how increasing demand for real world data is impacting on the business interests of medical device and diagnostics companies.
Clinical
AbbVie Move Against Data Transparency
Going against the proponents of disclosing clinical trial data, AbbVie has filed an injunction to prevent the European Medicines Agency from releasing detailed patient-level data from studies concerning its blockbuster drug, Humira (adalimumab), a treatment for rheumatoid arthritis.
Clinical
€144m Fund to Provide 200 Rare Disease Therapies by 2020
The European Commission (EC) has announced €144 million in funding to successfully diagnose most rare diseases and provide 200 therapies by 2020.
Clinical
GSK and Pfizer Join Medicines Patent Pool with AIDS Drugs
The global initiative designed to encourage patent holders to share commercial information with low cost generic pharmaceutical manufacturers announced last week the launch of a new collaboration to support low cost HIV/AIDS pharmaceuticals.
Clinical
FDA Halts Sensipar Trials after Teenage Participant Dies
Earlier this week, the FDA published a press release stating that it is halting all paediatric clinical trials of the drug Sensipar. The announcement follows the death of a 14 year old patient who took part in one of the studies.
Clinical
Cubist Answers the Call of the Wild in the Fight against Superbugs
An ambitious US biopharmaceutical seeks the assistance of Mother Nature in the battle against drug resistant bacteria, and its pioneering approach seems to have paid off as proverbial gold has been struck in a cave 1,600 feet below New Mexico’s Carlsbad Caverns National Park.
Clinical
UK Researchers Allowed the Use of Patented Drugs in Trials
Drug researchers could run comparator studies concerning patented drugs in the UK, without infringement consequences, as a result of an update of the country’s Patents Act.